Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News Professor Adam Croft receives funding as part of £1MM project tackling autoimmune conditions Birmingham's Institute of Inflammation and Ageing academic Professor Adam Croft has secured funding as part of ten new autoimmunity research projects to tackle the root cause of life-changing autoimmune conditions.
News Drug could more effectively treat patients hospitalised with COVID-19 pneumonia, early stage research finds
05 February 2021 Severely frail individuals with COVID-19 are three times more likely to die, study finds New research led by the University of Birmingham has revealed for the first time the extent to which frailty increases the risk of mortality in COVID-19 patients.
15 January 2021 Government is missing its key healthy ageing targets and must act now, report finds The COVID-19 pandemic has highlighted stark inequalities in healthy life expectancy, according to a report into ageing published on Friday 15 January.
11 December 2020 University awarded over £1.5 million for new MB-PhD programme The University has been awarded funding for a new MB-PhD programme to support three intercalating students a year for five years in areas of research relevant to musculoskeletal and other inflammatory diseases.
25 November 2020 New breakthrough in the treatment of rheumatoid arthritis People with rheumatoid arthritis could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores.
15 October 2020 University receives two awards to mark gender equality The College of Medical and Dental Sciences has achieved the Athena SWAN Silver award from the Athena SWAN Foundation, recognising the College's commitment to gender equality.
07 October 2020 Vitamin D deficiency increased risk of COVID in healthcare workers, new UK study shows Research finds healthcare workers who self-isolated after developing COVID-19 symptoms were more likely to have a vitamin D deficiency, with workers from Black, Asian or ethnic minority backgrounds particularly affected.
21 September 2020 How lupus patients would like to be treated: study identifies physician behaviours that help build trust and medical security Lupus patients – and those with related systemic autoimmune diseases – often experience persisting medical insecurity and negative healthcare-behaviours.
11 August 2020 Coronavirus-related children's diseases linked to blood cell changes A disease occurring in children and linked to COVID-19 has significant changes in white blood cells.
28 July 2020 Researchers discover chemical messenger that instructs tissue cells to become aggressive A University of Birmingham team have established that a chemical messenger released by blood vessels instructs tissue cells to become aggressive and destroy joints, a classic symptom of rheumatoid arthritis.
14 July 2020 UK children's intensive care units come together to offer first nationwide insight into new condition in children thought to be related to COVID-19 A UK study into critically ill children admitted to paediatric intensive care units with symptoms of a rare, new inflammatory syndrome, has offered the first nationwide insights into the true extent of the condition.
17 June 2020 Birmingham professor awarded prestigious Carol Nachman prize for Rheumatology Professor Christopher Buckley has been awarded the 2020 Carol Nachman prize based on outstanding innovate research activities in the field of rheumatology.
10 June 2020 First drugs announced in major COVID-19 drugs trial Two UK drugs companies will be the first to partner with the Universities of Birmingham and Oxford as part of a major new UK drugs trial to test potential therapeutics to treat patients hospitalised with COVID-19.